We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

82 hedge funds and large institutions have $113M invested in abrdn Life Sciences Investors in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

78% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 18

14% more funds holding

Funds holding: 72 → 82 (+10)

2.21% less ownership

Funds ownership: 34.7% → 32.49% (-2.2%)

9% less capital invested

Capital invested by funds: $125M → $113M (-$11.8M)

Holders
82
Holders Change
+10
Holders Change %
+13.89%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
32
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.07M
2
RCM
Rivernorth Capital Management
Florida
+$1.66M
3
FHA
Flagship Harbor Advisors
Massachusetts
+$1.22M
4
Raymond James Financial
Raymond James Financial
Florida
+$1M
5
FAM
Formidable Asset Management
Ohio
+$866K

Top Sellers

Rank Fund Capital Flow
1
SIA
Sit Investment Associates
Minnesota
-$5.47M
2
SCM
Saba Capital Management
New York
-$3.27M
3
AIA
Absolute Investment Advisers
Florida
-$2.81M
4
AA
AQR Arbitrage
Connecticut
-$1.44M
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
QC
51
Quantedge Capital
Singapore
$146K +$156K +11,520 New
NFG
52
Nations Financial Group
Iowa
$142K -$6.77K -500 -4%
Envestnet Asset Management
53
Envestnet Asset Management
Illinois
$140K +$150K +11,058 New
Millennium Management
54
Millennium Management
New York
$135K +$144K +10,658 New
Cambridge Investment Research Advisors
55
Cambridge Investment Research Advisors
Iowa
$134K +$142K +10,522 New
WAP
56
Wealthcare Advisory Partners
Pennsylvania
$131K +$139K +10,301 New
PA
57
Parallel Advisors
California
$61.3K -$13.6K -1,001 -17%
Wells Fargo
58
Wells Fargo
California
$57.1K -$11.7K -863 -16%
Comerica Bank
59
Comerica Bank
Texas
$52.7K +$2.04K +151 +4%
CWC
60
Carolinas Wealth Consulting
North Carolina
$44K – – –
CFD
61
Creative Financial Designs
Indiana
$35.7K – – –
NIM
62
Nexus Investment Management
Ontario, Canada
$27.2K +$20.2K +1,489 New
BTD
63
BankPlus Trust Department
Mississippi
$27.1K – – –
FFWM
64
Future Financial Wealth Management
Ohio
$25.4K – – –
CAM
65
Costello Asset Management
Pennsylvania
$21K +$22.4K +1,656 New
GWM
66
Geneos Wealth Management
Colorado
$20.8K +$22.2K +1,642 New
VWA
67
VSM Wealth Advisory
Maryland
$18.7K +$1.37K +101 +7%
WSFS
68
Wilmington Savings Fund Society
Delaware
$15.2K – – –
Bessemer Group
69
Bessemer Group
New Jersey
$12K – – –
CA
70
CoreCap Advisors
Michigan
$11.2K – – –
PS
71
Principal Securities
Iowa
$10.1K – – –
Carson Wealth (CWM LLC)
72
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
CAM
73
Creekmur Asset Management
Illinois
$2.74K +$108 +8 +4%
WA
74
WPG Advisers
Maryland
$2.15K +$2.29K +169 New
ACA
75
Atlas Capital Advisors
Wyoming
$1.75K – – –
1 2
3
4

HQL Hedge Fund Activity: Q1 2025 in Review

82 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2025, worth a combined $113M — down 9.4% from $125M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HQL positions and 7 closed out — a net gain of 11 holders — while 32 added to existing stakes and 18 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.07M. The largest seller was Sit Investment Associates, exiting entirely with an estimated $5.47M sold.

  • 82 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2025, up from 72 in Q4 2024.
  • Funds reported $113M of abrdn Life Sciences Investors stock for Q1 2025, down 9.4% quarter-over-quarter.
  • 18 funds opened new abrdn Life Sciences Investors positions in Q1 2025 and 7 closed out, a net change of +11 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2025 was Morgan Stanley, an estimated $2.07M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2025 was Sit Investment Associates, an estimated $5.47M sold.

Based on aggregated 13F filings for Q1 2025.